Head and Neck Squamous Cell Carcinoma Clinical Trials
Head and Neck Squamous Cell Carcinoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for head and Neck Squamous Cell Carcinoma. Corterve aggregates actively recruiting Head and Neck Squamous Cell Carcinoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Head and Neck Squamous Cell Carcinoma studies
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801PHASE1M.D. Anderson Cancer CenterAdvanced Endometrial CarcinomaHouston, Texas
- Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentNCT06589804PHASE3National Cancer Institute (NCI)Metastatic Head and Neck Squamous Cell CarcinomaLittle Rock, Arkansas
- BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196PHASE2National Cancer Institute (NCI)Clinical Stage III Cutaneous Melanoma AJCC v8Phoenix, Arizona
- CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaNCT07659678PHASE2Washington University School of MedicineHead and Neck Squamous Cell CarcinomaSt Louis, Missouri
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerNCT07195734PHASE2National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Tucson, Arizona
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043PHASE1, PHASE2AstraZenecaMelanomaGrand Rapids, Michigan
- Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell CarcinomaNCT04671667PHASE2National Cancer Institute (NCI)Recurrent Head and Neck Squamous Cell CarcinomaBirmingham, Alabama
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsNCT04429542PHASE1Bicara TherapeuticsHead and Neck Squamous Cell CarcinomaLa Jolla, California
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramNCT06265285PHASE2Mayo ClinicAdvanced Esophageal Squamous Cell CarcinomaJacksonville, Florida
- FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCNCT06788990PHASE2, PHASE3Bicara TherapeuticsMetastatic Head and Neck Squamous Cell CarcinomaBirmingham, Alabama
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNCT06465069PHASE1Eli Lilly and CompanyMetastatic Solid TumorDuarte, California
- High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerNCT06992427PHASE3Alliance for Clinical Trials in OncologyHead and Neck Squamous Cell CarcinomaGilbert, Arizona
Head and Neck Squamous Cell Carcinoma trials by state
Head and Neck Squamous Cell Carcinoma trials by metro
Frequently asked questions
- How do I find recruiting Head and Neck Squamous Cell Carcinoma clinical trials?
- Browse the actively recruiting Head and Neck Squamous Cell Carcinoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Head and Neck Squamous Cell Carcinoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Head and Neck Squamous Cell Carcinoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.